Aquilo Capital, L.P. 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:37 pm Sale | 2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital, L.P. | 14,085 1.100% | -56,911 (-80.16%) | Filing |
| 2023-02-14 11:28 am Purchase | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital, L.P. | 70,995 7.500% | 16,954 (+31.37%) | Filing |
| 2022-02-14 3:20 pm Sale | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital, L.P. | 54,041 5.900% | -5,988 (-9.97%) | Filing |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Aquilo Capital, L.P. | 60,029 8.400% | -9,665 (-13.87%) | Filing |